By Loni Branon 17 Aug 2017
A Look At Prevalence and Current Clinical Trial Activity – Is There More We Could Be Doing?
Use the power of over 35 years of data to discover global trends impacting today’s drug development industry.
How it helps
Easily identify opportunities or market saturation with Pharmaprojects. Our expert analysts track new molecular targets entering pipelines, in-and-out licensing activity and conduct primary research on your behalf to uncover additional information around your chosen drug or company. Pharmaprojects links to Trialtrove’s clinical trial intelligence, leveraging the power of both to ensure you stay on top of every clinical trial development for your disease, company, or therapeutic mechanism of interest.
How it works
Pharmaprojects’ intuitive interface supports fast access to drug development results for specific diseases, companies, and countries. These results can appear as graphics-driven analytic dashboards or exportable files.
Quickly tap into Pharmaprojects’ comprehensive data to support your next R&D decision.
Analyst reviewed data and enriched content
Development history, licensing data, searchable molecular structures and more
Get an analysis of drug development trends dating back over 35 years
Unlimited support for your research from experienced industry analysts
Instantly and easily generate custom tables and charts of key trial attributes
By Jake Mathon 28 Jun 2017
Pharma companies have repurposed drugs into single pill combinations for years.
Pharmaprojects, Sitetrove, Trialtrove
19 Apr 2017
The R&D Annual Review webinar is happening soon. Take a look back at pharma R&D in 2016 and look ahead to the remainder of the year to get expert insight from the senior experts at Pharma Intelligence during this free webinar.
By Ian Lloyd 13 Apr 2017
Following on from our review of trends in the current pharmaceutical R&D pipeline, published in March 2017, this supplement takes a look at the industry’s success stories of 2016 – the drugs which were launched on to the market for the first time during the year.
Pharmaprojects, Biomedtracker, Trialtrove
By Rachel Meighan-Mantha 22 Mar 2017
The field of epigenetics is rapidly expanding and as interest continues to grow, epigenetics has become an increasingly promising area for research.
22 Mar 2017
With the recent controversy surrounding the approval and launch of the first wave of PCSK9 inhibitors (focussing mainly on the extremely high cost in comparison to statin therapies), it may be easy to forget that the dyslipidaemia space has also been plagued by a number of high profile and costly failures too.
By Doro Shin 25 Jan 2016
On April 27, 2016, Informa will host its inaugural Clinical and Research Excellence (CARE) Awards to honor those in clinical R&D who are making a difference and committed to making human lives better.
By Benjamin Graham 01 Dec 2015
For World AIDS Day, we look at current and upcoming novel single tablet regimens (STRs) for HIV treatment. STR’s primary advantage is that they simplify treatment and this leads to greater patient adherence, lower resistance emergence and overall improved outcomes over more traditional cocktails of antiretroviral drugs
By Jonathan Stephens 24 Nov 2015
When considering cancer in men, prostate cancer could be described as ‘all too frequent’. Indeed, the annual month of ‘Movember’ is here once again and serves as a stark reminder that men worldwide are still dying too young from this disease.Worldwide prostate cancer is currently the second most common cancer in males and the fourth most common cancer overall, with over 1.1 million new cases diagnosed in 2012
Ian specializes in
+30 year(s) experience
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: